Taylor Chin is an Associate on the Life Sciences Investing team at Goldman Sachs, where she helps evaluate private biotech companies with a focus on therapeutics. During graduate school, Taylor’s dissertation research focused on using mathematical modeling and novel data sources like cell phone data for population-level mobility patterns to understand infectious disease transmission. Based on her interest in disease surveillance and global health interventions in low-resource settings, she has conducted research quantifying the impact of vaccination programs in the Rohingya refugee camps in Cox’s Bazar, helped set up environmental surveillance systems, and assessed the role of human mobility on the spread of SARS-CoV-2 in Bangladesh. Taylor also served as an ORISE Research Fellow on the CDC COVID-19 Modeling Task Force, where she conducted modeling analyses to assess vaccination and post-pandemic surveillance strategies. Taylor holds an AB in Public and International Affairs from Princeton University and a Ph.D. in Epidemiology from the Harvard T.H. Chan School of Public Health. Prior to graduate school, she worked as a strategy consultant at EY-Parthenon in New York City.
